Table 2.
Groups | Newly diagnosed type 1 diabetics | Siblings | Parents | Normal controls | Sibling controls | Parents controls | |
---|---|---|---|---|---|---|---|
Total subject number | 69 | 76 | 116 | 53 | 20 | 57 | |
Subjects with iNKThi | 69/69 | 76/76 | 116/116 | 53/53 | 20/20 | 57/57 | |
% iNKThi cells ± SE | 0.152 ± 0.02 | 0.219 ± 0.02 | 0.156 ± 0.01 | 0.169 ± 0.02 | 0.219 ± 0.07 | 0.154 ± 0.02 | |
# iNKThi cells ± SE | 385.9 ± 60.6 | 563.1 ± 68.0 | 328.8 ± 33.0 | 827.5 ± 101.0 | 1071 ± 324.1 | 811.9 ± 111.5 | |
Subjects with iNKTlo (%) | 16/69 (23.2) | 22/76 (28.9) | 25/116 (21.5) | 0/53 | 0/20 | 0/57 | |
% iNKTlo cells ± SE | 0.280 ± 0.10 | 0.147 ± 0.06 | 0.264 ± 0.08 | – | – | – | |
# iNKTlo cells ± SE | 1232 ± 525.1 | 379.2 ± 146.9 | 634.9 ± 196.2 | – | – | – | |
Subjects with NKTlo and CRTAM expression (%) | 12/16 (75) | 19/22 (86.3) | 10/15 (66.6) | – | – | – |